Articles written by M.E. Garza - Benzinga

This Stock Holds The Key The Auto Industry Has Been Looking For

Lpath: Things Looking Brighter for Bioactive Lipid-Targeted Therapeutics Leader

Trading The Market's Top Triglyceride Challengers

Upcoming Dividend Leak Spurs More Buying For Neptune

Technical and Fundamental Reasons Why Neptune (NEPT) Should Be In Your Portfolio

Insider Buy at NVAX Spurs Some Speculation

Why Ampio's Rebound Run May Not Be Done

Corcept Therapeutics: One and Done or More to Come?

Trovagene: Built on Experience and Ready to Move Higher

Thinly Traded BioLineRx Shares Move on Hepatitis C Deal

Two Biotechs That Continue to Attract Positive Attention From Investors

The Drama Continues: Cell Therapeutics

Biotech Traders Have Astex Pharmaceuticals in their Sights

Achillion's Hep C Pipeline Likely Can't Compete

On the move: Shares of PROLOR Biotech Inc.

San Francisco Health Care Conferences Provide Plenty of Buzz and Chatter

Merck Hands Exelixis $12 Million Up Front For a Preclinical Compound Program

Key Phase IIb Clinical Trial Results Await Smoking Cessation Player This Week

Ampio Says Factually Inaccurate and Purposely Misleading Information Panicked Market

Threshold Pharmaceuticals Making Good Clinical Progress on Several Fronts